Business
Press Release Mar 19 2025
Marksans Pharma Limited has informed the Exchange regarding a press release dated March 19, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in the UK, Relonchem Limited receives Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated March 19, 2025, titled \"Marksans Pharma Limited s wholly owned subsidiary in the UK, Relonchem Limited receives Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA\". View Attachment","length":416,"tagName":"div"}]